Benzazepine derivatives as MAO-B inhibitors

Details for Australian Patent Application No. 2004283452 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Jolidon, Synese; Wostl, Wolfgang; Thomas, Andrew William; Wyler, Rene; Rodriguez Sarmiento, Rosa Maria

Agent Spruson & Ferguson

Pub. Number AU-A-2004283452

PCT Pub. Number WO2005/039591

Priority 03024297.8 23.10.03 EP

Filing date 14 October 2004

Wipo publication date 6 May 2005

International Classifications

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/039591 Priority application(s): WO2005/039591

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283453-Sulfur compounds for enhancing coffee aroma and resultant products containing same

2004283448-Use of xenon for the prevention of programmed cell death